Literature DB >> 30633978

Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights.

Ammad Ahmad Farooqi1, Marc de la Roche2, Mustafa B A Djamgoz3, Zahid H Siddik4.   

Abstract

Colorectal cancer is a multifaceted disease which is therapeutically challenging. Based on insights gleaned from almost a quarter century of research, it is obvious that deregulation of spatio-temporally controlled signaling pathways play instrumental role in development and progression of colorectal cancer. High-throughput technologies have helped to develop a sharper and broader understanding of the wide ranging signal transduction cascades which also contribute to development of drug resistance, loss of apoptosis and, ultimately, of metastasis. In this review, we have set the spotlight on role of JAK/STAT, TGF/SMAD, Notch, WNT/β-Catenin, SHH/GLI and p53 pathways in the development and progression of colorectal cancer. We have also highlighted recent reports on TRAIL-mediated pathways and molecularly distinct voltage-gated sodium channels in colorectal cancer.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30633978     DOI: 10.1016/j.semcancer.2019.01.001

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  36 in total

Review 1.  Genomic and molecular alterations in human inflammatory bowel disease-associated colorectal cancer.

Authors:  Marie Muller; Franck Hansmannel; Djesia Arnone; Myriam Choukour; Ndeye Coumba Ndiaye; Tunay Kokten; Rémi Houlgatte; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-04-08       Impact factor: 4.623

2.  Colorectal Cancer in the Adolescent and Young Adult Population.

Authors:  Y Nancy You; Lucas D Lee; Benjamin W Deschner; David Shibata
Journal:  JCO Oncol Pract       Date:  2020-01

3.  Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA.

Authors:  Yuan Huang; Nannan Liu; Jing Liu; Yeying Liu; Chuchu Zhang; Shuaiyu Long; Guang Luo; Lingling Zhang; Yingjie Zhang
Journal:  Cell Cycle       Date:  2019-11-14       Impact factor: 4.534

4.  Comprehensive bioinformatics analysis of functional molecules in colorectal cancer.

Authors:  Tao Meng; Zhangzhang Lan; Xiaoling Zhao; Li Niu; Chuan Chen; Wenyong Zhang
Journal:  J Gastrointest Oncol       Date:  2022-02

5.  Effects of YAP1 and SFRP2 overexpression on the biological behavior of colorectal cancer cells and their molecular mechanisms.

Authors:  Zhenzhen Bai; Qingqing Wu; Cong Zhang; Jing Chen; Liyu Cao
Journal:  J Gastrointest Oncol       Date:  2021-08

6.  Inflammation-induced colon cancer in uPA-deficient mice is associated with a deregulated expression of Notch signaling pathway components.

Authors:  Hara Afaloniati; George S Karagiannis; Emmanouel Karavanis; Theophano A Psarra; Anastasios Karampatzakis-Kouritas; Theofilos Poutahidis; Katerina Angelopoulou
Journal:  Mol Cell Biochem       Date:  2019-11-22       Impact factor: 3.396

Review 7.  Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities.

Authors:  Wamidh H Talib; Ahmad Riyad Alsayed; Alaa Abuawad; Safa Daoud; Asma Ismail Mahmod
Journal:  Molecules       Date:  2021-04-25       Impact factor: 4.411

Review 8.  Genomic landscape of colorectal carcinogenesis.

Authors:  Jin Cheon Kim; Walter F Bodmer
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-20       Impact factor: 4.553

Review 9.  Understanding the regulation of β-catenin expression and activity in colorectal cancer carcinogenesis: beyond destruction complex.

Authors:  Y Taank; N Agnihotri
Journal:  Clin Transl Oncol       Date:  2021-08-23       Impact factor: 3.405

10.  Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis.

Authors:  Tian Fang; Tingting Liang; Yizhuo Wang; Haitao Wu; Shuhan Liu; Linying Xie; Jiaying Liang; Chang Wang; Yehui Tan
Journal:  BMC Gastroenterol       Date:  2021-07-23       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.